2025医药健康回眸:在进阶中创新,于规范中前行

21世纪经济报道
Dec 30, 2025

2025年,是中国生物医药行业在挑战中坚守初心、于变局中锚定方向的一年。  这一年,行业融资市场的寒意未完全消退。数据显示,2025年上半年,国内创新药企业完成134起融资,数量创近十年同期新低;一级市场公开交易笔数与总额,亦呈逐月下降趋势。  所幸,寒意挡不住创新的光芒。这一年,本土药企凭借扎实的创新实力主动突围,一边抢抓BD(商业拓展)机遇,让本土创新价值在国际舞台兑现,为行业稳稳守住关键...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10